Ian David Postlethwaite
No más puestos en curso
Perfil
Ian David Postlethwaite served as the Chief Executive Officer of Ellerman Investments Ltd.
from 1997 to 2002.
He also served as the Chief Executive Officer of the Association of Friendly Societies Conference and as the Deputy Chairman of Shoreham Port Authority in 2015-2016.
He was a Director of PDS Operating Corp.
and served as the Secretary, Executive Director & Finance Director of Allergy Therapeutics Plc from 2002 to 2016.
From 2016 to 2019, he was the Chief Financial Officer, Secretary & Director of NetScientific Plc.
He was also a Director of Glycotest, Inc. and a Non-Executive Director of ProAxsis Ltd.
Mr. Postlethwaite obtained his undergraduate degree from the University of Aston.
Antiguos cargos conocidos de Ian David Postlethwaite.
| Empresas | Cargo | Fin |
|---|---|---|
| NETSCIENTIFIC PLC | Director Ejecutivo | 30/04/2020 |
| Shoreham Port Authority | Director/Miembro de la Junta | 31/12/2016 |
| ALLERGY THERAPEUTICS PLC | Director Financiero/CFO | 10/06/2016 |
Ellerman Investments Ltd.
 Ellerman Investments Ltd. Financial ConglomeratesFinance Ellerman Investments Ltd. provides financial services. The private company is based in London, UK. and has subsidiaries in United Kingdom. Ellerman Investments was founded in 1984. | Director Ejecutivo | 01/01/2002 |
PDS Operating Corp.
 PDS Operating Corp. BiotechnologyHealth Technology PDS Operating Corp. operates as a biopharmaceutical company. It develops immunotherapies for cancer and infectious disease. The firm’s versamune is capable of potent activation of immune cells without the side effects of traditional vaccines, efficiently delivering disease related antigen targets to the immune system and promoting antigen processing to present antigen appropriately to generate both strong prophylactic and therapeutic immune responses to disease. The company was founded by Frank K. Bedu-Addo and Gregory L. Conn and is headquartered in Princeton, NJ. | Director/Miembro de la Junta | - |
Formación de Ian David Postlethwaite.
| University of Aston | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ALLERGY THERAPEUTICS PLC | Health Technology |
| NETSCIENTIFIC PLC | Health Technology |
| Empresas privadas | 6 |
|---|---|
Ellerman Investments Ltd.
Ellerman Investments Ltd. Financial ConglomeratesFinance Ellerman Investments Ltd. provides financial services. The private company is based in London, UK. and has subsidiaries in United Kingdom. Ellerman Investments was founded in 1984. | Finance |
| Association of Friendly Societies Conference | |
| Shoreham Port Authority | Government |
ProAxsis Ltd.
 ProAxsis Ltd. Pharmaceuticals: MajorHealth Technology ProAxsis Ltd. manufactures and markets pharmaceutical products . It offers clinical research and research and development services. The company was founded by Lorraine Martin and Brian Walker in August 2013 and is headquartered in Belfast, the United Kingdom. | Health Technology |
Glycotest, Inc.
 Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Electronic Technology |
PDS Operating Corp.
PDS Operating Corp. BiotechnologyHealth Technology PDS Operating Corp. operates as a biopharmaceutical company. It develops immunotherapies for cancer and infectious disease. The firm’s versamune is capable of potent activation of immune cells without the side effects of traditional vaccines, efficiently delivering disease related antigen targets to the immune system and promoting antigen processing to present antigen appropriately to generate both strong prophylactic and therapeutic immune responses to disease. The company was founded by Frank K. Bedu-Addo and Gregory L. Conn and is headquartered in Princeton, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Ian David Postlethwaite
